S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
A 'soft landing' or a recession? How each one might affect America's households and businesses
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
How major US stock indexes fared Friday, 12/8/2023
MarketBeat Week in Review – 12/4 - 12/8
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
Indiana secretary of state appeals ruling for US Senate candidate seeking GOP nod
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What is carbon capture and why does it keep coming up at COP28?
Polish truck drivers are blocking the border with Ukraine. It's hurting on the battlefield
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
A 'soft landing' or a recession? How each one might affect America's households and businesses
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
How major US stock indexes fared Friday, 12/8/2023
MarketBeat Week in Review – 12/4 - 12/8
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
Indiana secretary of state appeals ruling for US Senate candidate seeking GOP nod
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What is carbon capture and why does it keep coming up at COP28?
Polish truck drivers are blocking the border with Ukraine. It's hurting on the battlefield
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
A 'soft landing' or a recession? How each one might affect America's households and businesses
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
How major US stock indexes fared Friday, 12/8/2023
MarketBeat Week in Review – 12/4 - 12/8
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
Indiana secretary of state appeals ruling for US Senate candidate seeking GOP nod
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What is carbon capture and why does it keep coming up at COP28?
Polish truck drivers are blocking the border with Ukraine. It's hurting on the battlefield
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
A 'soft landing' or a recession? How each one might affect America's households and businesses
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
How major US stock indexes fared Friday, 12/8/2023
MarketBeat Week in Review – 12/4 - 12/8
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
Indiana secretary of state appeals ruling for US Senate candidate seeking GOP nod
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What is carbon capture and why does it keep coming up at COP28?
Polish truck drivers are blocking the border with Ukraine. It's hurting on the battlefield

Arcosa Stock Price, News & Analysis (NYSE:ACA)

$77.77
+0.22 (+0.28%)
(As of 12/8/2023 ET)
Compare
Today's Range
$76.76
$78.40
50-Day Range
$65.14
$77.74
52-Week Range
$52.04
$79.38
Volume
207,121 shs
Average Volume
206,227 shs
Market Capitalization
$3.79 billion
P/E Ratio
13.23
Dividend Yield
0.26%
Price Target
$88.00

Arcosa MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
13.2% Upside
$88.00 Price Target
Short Interest
Healthy
0.93% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-4.59
Upright™ Environmental Score
News Sentiment
0.88mentions of Arcosa in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
13.22%
From $2.95 to $3.34 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.22 out of 5 stars

Construction Sector

35th out of 98 stocks

Fabricated Structural Metal Products Industry

2nd out of 5 stocks


ACA stock logo

About Arcosa Stock (NYSE:ACA)

Arcosa, Inc., together with its subsidiaries, provides infrastructure-related products and solutions for the construction, engineered structures, and transportation markets in North America. It operates through three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment offers natural and recycled aggregates; specialty materials; and construction site support equipment, including trench shields and shoring products for residential and non-residential construction, and specialty/other products, as well as for infrastructure construction. The Engineered Structures segment provides utility structures, wind towers, traffic structures, and telecommunication structures for electricity transmission and distribution, wind power generation, highway road construction, and wireless communication markets. The Transportation Products segment offers inland barges, fiberglass barge covers, winches, marine hardware, and steel components for railcars; cast components for industrial and mining sectors; and axles, circular forgings, and coupling devices for freight, tank, locomotive, and passenger rail transportation equipment, as well as other industrial uses. Arcosa, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

ACA Stock Price History

ACA Stock News Headlines

Arcosa Inc ACA
All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
Estimating The Fair Value Of Arcosa, Inc. (NYSE:ACA)
Arcosa, Inc. (NYSE:ACA) Q3 2023 Earnings Call Transcript
Arcosa: Q3 Earnings Snapshot
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Arcosa, Inc. Announces Third Quarter 2023 Results
Sidoti & Co. Upgrades Arcosa (ACA)
5 Low-Leverage Stocks to Buy as Market Woes Compound
President & CEO of Arcosa Makes $643K Sale
Arcosa: Some Warning Signs
Arcosa, Inc. Announces Second Quarter 2023 Results
Arcosa (NYSE: ACA)
See More Headlines
Receive ACA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arcosa and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 10/31 Dividend
10/12/2023
Dividend Payable
10/31/2023
Last Earnings
11/02/2023
Today
12/09/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/22/2024

Industry, Sector and Symbol

Industry
Fabricated structural metal products
Sub-Industry
N/A
CUSIP
000833103
Fax
N/A
Employees
5,230
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$88.00
High Stock Price Target
$90.00
Low Stock Price Target
$85.00
Potential Upside/Downside
+13.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$245.80 million
Pretax Margin
16.14%

Debt

Sales & Book Value

Annual Sales
$2.24 billion
Cash Flow
$5.40 per share
Book Value
$45.09 per share

Miscellaneous

Free Float
48,126,000
Market Cap
$3.79 billion
Optionable
Not Optionable
Beta
0.61
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report














ACA Stock Analysis - Frequently Asked Questions

Should I buy or sell Arcosa stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Arcosa in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ACA shares.
View ACA analyst ratings
or view top-rated stocks.

What is Arcosa's stock price target for 2024?

4 Wall Street analysts have issued 12-month target prices for Arcosa's shares. Their ACA share price targets range from $85.00 to $90.00. On average, they anticipate the company's stock price to reach $88.00 in the next year. This suggests a possible upside of 13.2% from the stock's current price.
View analysts price targets for ACA
or view top-rated stocks among Wall Street analysts.

How have ACA shares performed in 2023?

Arcosa's stock was trading at $54.34 on January 1st, 2023. Since then, ACA shares have increased by 43.1% and is now trading at $77.77.
View the best growth stocks for 2023 here
.

Are investors shorting Arcosa?

Arcosa saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 446,800 shares, an increase of 19.8% from the October 31st total of 373,100 shares. Based on an average trading volume of 229,800 shares, the days-to-cover ratio is currently 1.9 days. Approximately 0.9% of the company's stock are sold short.
View Arcosa's Short Interest
.

When is Arcosa's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 22nd 2024.
View our ACA earnings forecast
.

How were Arcosa's earnings last quarter?

Arcosa, Inc. (NYSE:ACA) posted its quarterly earnings results on Thursday, November, 2nd. The company reported $0.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.66 by $0.07. The firm had revenue of $591.70 million for the quarter, compared to analyst estimates of $586.04 million. Arcosa had a net margin of 12.88% and a trailing twelve-month return on equity of 6.04%. The firm's revenue was down 2.0% compared to the same quarter last year. During the same period last year, the firm posted $0.70 EPS.

How often does Arcosa pay dividends? What is the dividend yield for Arcosa?

Arcosa declared a quarterly dividend on Thursday, September 7th. Investors of record on Friday, October 13th will be given a dividend of $0.05 per share on Tuesday, October 31st. This represents a $0.20 annualized dividend and a dividend yield of 0.26%. The ex-dividend date of this dividend is Thursday, October 12th.
Read our dividend analysis for ACA
.

Is Arcosa a good dividend stock?

Arcosa (NYSE:ACA) pays an annual dividend of $0.20 per share and currently has a dividend yield of 0.26%. The dividend payout ratio is 3.40%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ACA will have a dividend payout ratio of 5.99% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ACA.

What is Antonio Carrillo's approval rating as Arcosa's CEO?

15 employees have rated Arcosa Chief Executive Officer Antonio Carrillo on Glassdoor.com. Antonio Carrillo has an approval rating of 91% among the company's employees. This puts Antonio Carrillo in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Arcosa own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Arcosa investors own include DexCom (DXCM), AbbVie (ABBV), Walt Disney (DIS), Advanced Micro Devices (AMD), NVIDIA (NVDA), Splunk (SPLK), AT&T (T), Xilinx (XLNX), Activision Blizzard (ATVI) and Alibaba Group (BABA).

Who are Arcosa's major shareholders?

Arcosa's stock is owned by a number of institutional and retail investors. Top institutional investors include Loomis Sayles & Co. L P (2.11%), Morgan Stanley (1.40%), Northern Trust Corp (1.33%), Charles Schwab Investment Management Inc. (1.23%), The Manufacturers Life Insurance Company (1.20%) and Bank of New York Mellon Corp (0.98%). Insiders that own company stock include Antonio Carrillo, Bryan Stevenson, Gail M Peck, Jesse E Jr Collins, Kerry S Cole, Mary E Henderson and Ronald J Gafford.
View institutional ownership trends
.

How do I buy shares of Arcosa?

Shares of ACA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:ACA) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -